These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11705517)

  • 1. Montelukast for persistent asthma.
    Lipworth BJ; Fowler S; Currie G
    Lancet; 2001 Oct; 358(9291):1455; author reply 1456. PubMed ID: 11705517
    [No Abstract]   [Full Text] [Related]  

  • 2. [Non-interventional study with remarkable results. Improved asthma control and quality of life with montelukast].
    MMW Fortschr Med; 2009 May; 151(21):40-1. PubMed ID: 19537636
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of montelukast in patients with persistent asthma using inhaled corticosteroids plus additional second-line therapy.
    Currie GP; Anderson WJ; Lee DK
    J Allergy Clin Immunol; 2005 Jul; 116(1):230. PubMed ID: 15990804
    [No Abstract]   [Full Text] [Related]  

  • 4. In patients with asthma that is not well controlled with inhaled steroids, does salmeterol (Serevent) or montelukast (Singulair) offer better symptom relief?
    Cash R; Blonski J
    J Fam Pract; 2001 Sep; 50(9):802. PubMed ID: 11674917
    [No Abstract]   [Full Text] [Related]  

  • 5. [Leukotriene antagonists against bronchial asthma. Not a replacement for steroids].
    MMW Fortschr Med; 1999 Sep; 141(38):56. PubMed ID: 10904622
    [No Abstract]   [Full Text] [Related]  

  • 6. Montelukast for persistent asthma.
    Morice AH
    Lancet; 2001 Oct; 358(9291):1455-6. PubMed ID: 11705516
    [No Abstract]   [Full Text] [Related]  

  • 7. Montelukast versus inhaled corticosteroids as monotherapy for prevention of asthma: which one is best?
    Miceli Sopo S; Onesimo R; Radzik D; Scala G; Cardinale F
    Allergol Immunopathol (Madr); 2009; 37(1):26-30. PubMed ID: 19268058
    [No Abstract]   [Full Text] [Related]  

  • 8. Montelukast for persistent asthma.
    Szczeklik A; Mastalerz L; Nizankowska E; Sanak M
    Lancet; 2001 Oct; 358(9291):1456-7. PubMed ID: 11705519
    [No Abstract]   [Full Text] [Related]  

  • 9. [Leukotriene antagonists].
    Mallet JP
    Allerg Immunol (Paris); 1999 Apr; 31(4):113-6. PubMed ID: 10370724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids.
    Phipatanakul W; Greene C; Downes SJ; Cronin B; Eller TJ; Schneider LC; Irani AM
    Ann Allergy Asthma Immunol; 2003 Jul; 91(1):49-54. PubMed ID: 12877449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Importance of leukotriene antagonists in asthma therapy raised].
    MMW Fortschr Med; 2008 Mar; 150(13):44-5. PubMed ID: 18522358
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience with montelukast, a leukotriene receptor antagonist, in pediatric patients with asthma].
    Vega López M; Jiménez Ferral R
    Rev Alerg Mex; 2001; 48(5):133-6. PubMed ID: 11759254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Montelukast for mild and exercise-induced asthma.
    Adelman A
    J Fam Pract; 1998 Nov; 47(5):335. PubMed ID: 9834763
    [No Abstract]   [Full Text] [Related]  

  • 15. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy.
    Johnston NW; Mandhane PJ; Dai J; Duncan JM; Greene JM; Lambert K; Sears MR
    Pediatrics; 2007 Sep; 120(3):e702-12. PubMed ID: 17766511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of montelukast on asthma associated with rhinitis, and other triggers and co-morbidities.
    Pacheco Y; Freymond N; Devouassoux G
    J Asthma; 2014 Feb; 51(1):1-17. PubMed ID: 23834429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma.
    Davies GM; Dasbach EJ; Santanello NC; Knorr BA; Bratton DL
    Clin Ther; 2004 Nov; 26(11):1895-904. PubMed ID: 15639701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SIMPLE trial.
    D'Urzo AD
    Can Respir J; 2010; 17(2):56. PubMed ID: 20422059
    [No Abstract]   [Full Text] [Related]  

  • 19. Montelukast in childhood asthma.
    Mehta PN
    Indian Pediatr; 2000 Nov; 37(11):1201-9. PubMed ID: 11086302
    [No Abstract]   [Full Text] [Related]  

  • 20. Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study.
    Simons FE; Villa JR; Lee BW; Teper AM; Lyttle B; Aristizabal G; Laessig W; Schuster A; Perez-Frias J; Sekerel BE; Menten J; Leff JA
    J Pediatr; 2001 May; 138(5):694-8. PubMed ID: 11343045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.